Safety and immunogenicity of SC599, an oral live attenuated Shigella dysenteriae type-1 vaccine in healthy volunteers: Results of a Phase 2, randomized, double-blind placebo-controlled trial

Odile Launay, Christine Sadorge, Nathalie Jolly, Béatrice Poirier, Stéphane Béchet, Diane van der Vliet, Valérie Seffer, Nicola Fenner, Kelly Dowling, Raphaela Giemza,

Vaccine · 2009 · 44 citations · 17 references

Concepts

References

17